On January 3, 2022, the Board of Curis, Inc. appointed John A. Hohneker to serve on the Compensation Committee and the Clinical Program Committee, effective immediately, in each case until his successor is duly appointed and qualified or until his earlier resignation or removal.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.982 USD | +0.03% |
|
+1.93% | -45.24% |
Jul. 01 | Curis, Inc.(NasdaqCM:CRIS) added to Russell 3000E Value Index | CI |
Jul. 01 | Curis, Inc.(NasdaqCM:CRIS) added to Russell 3000E Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.24% | 41.14M | |
+24.72% | 46.56B | |
+45.38% | 41.67B | |
+0.08% | 41.16B | |
+32.84% | 32.4B | |
+20.94% | 28.18B | |
-6.35% | 28.1B | |
+48.77% | 14.52B | |
+47.41% | 13.74B | |
+3.33% | 12.17B |
- Stock Market
- Equities
- CRIS Stock
- News Curis, Inc.
- Curis, Inc. Appoints John A. Hohneker to Compensation Committee and the Clinical Program Committee